Please use this identifier to cite or link to this item: http://ir.swu.ac.th/jspui/handle/123456789/13494
Title: Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis
Authors: Yodying H.
Matsuda A.
Miyashita M.
Matsumoto S.
Sakurazawa N.
Yamada M.
Uchida E.
Keywords: Article
cancer patient
cancer prognosis
cancer surgery
chemoradiotherapy
cohort analysis
data base
disease free survival
esophagus cancer
esophagus surgery
human
lymph node metastasis
meta analysis
neutrophil lymphocyte ratio
observational study
outcome assessment
overall survival
platelet lymphocyte ratio
predictive value
retrospective study
systematic review
tumor invasion
cancer staging
Esophageal Neoplasms
lymphocyte
multimodality cancer therapy
neutrophil
pathology
prognosis
survival rate
thrombocyte
Blood Platelets
Combined Modality Therapy
Esophageal Neoplasms
Humans
Lymphocytes
Neoplasm Staging
Neutrophils
Prognosis
Survival Rate
Issue Date: 2016
Abstract: Background: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been reported to predict oncologic outcomes in patients with various types of cancer. However, their prognostic value in patients with esophageal cancer is unclear. In this meta-analysis, we evaluated the prognostic significance of NLR and PLR in esophageal cancer patients. Methods: We performed comprehensive searches of electronic databases to identify studies that evaluated the prognostic impact of pretreatment NLR and PLR in esophageal cancer patients. The end points were overall survival (OS), disease-free survival, and clinicopathologic parameters. A meta-analysis using random-effects models was performed to calculate hazard ratios (HRs) or odds ratios with 95 % confidence intervals (CIs). Results: Seven retrospective, observational, cohort studies involving 1540 patients were included. All seven studies evaluated NLR, and four evaluated PLR. Both high NLR (HR 1.40, 95 % CI 1.08–1.81, P = 0.01) and high PLR (HR 1.59, 95 % CI 1.14–2.21, P = 0.006) were significantly predictive of poorer OS. NLR was not a significant predictor of disease-free survival. High PLR (HR 1.85, 95 % CI 1.50–2.28, P < 0.00001) but not NLR was significantly predictive of poorer OS in a subgroup of patients who underwent curative surgery without neoadjuvant chemoradiation. Both high NLR and high PLR were significantly associated with deeper tumor invasion and lymph node metastasis. Conclusions: NLR and PLR are associated with tumor progression and are predictive of poorer survival in patients with esophageal cancer. These ratios may thus help to inform treatment decisions and predict treatment outcomes. © 2015, Society of Surgical Oncology.
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958177341&doi=10.1245%2fs10434-015-4869-5&partnerID=40&md5=2b180735aba023c4552a9ea50d20eccc
http://ir.swu.ac.th/jspui/handle/123456789/13494
ISSN: 10689265
Appears in Collections:SCOPUS 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.